{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:20:45Z","timestamp":1788967245374,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid use for chronic non-cancer pain remains common in the UK, despite limited evidence of long-term effectiveness. Delirium, a serious acute confusional state associated with increased mortality, is a known adverse effect of opioid use. Pharmacological differences between opioids may influence delirium risk, but comparative evidence is scarce. This study evaluated the association of opioid type and dosage with the risk of in-hospital delirium in non-cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using electronic health records (EHRs) from a tertiary care hospital in northwest England (September 26, 2014\u2013December 31, 2020). Adult (\u2265\u200918 years) without cancer who were administered with opioids during admission were included. Delirium was identified using the 4 \u2018A\u2019s Test or through a combination of ICD-10 codes and new-onset confusion scores (=\u20093) on the National Early Warning Score. Daily opioid doses were converted to daily morphine milligram equivalents (MME\/day) to assess the effect of dose across different opioid types. Incidence rates were calculated by opioid type and opioid dosage. Cox regression models, adjusted for confounders, were used to evaluate delirium risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 50,586 opioid-exposed patients (mean [SD] age, 55 [20] years; 53% female), 867 patients (1.7%) experienced delirium during their first hospital admission (mean [SD] age, 75.1 [16.7] years). Compared to codeine, oxycodone (hazard ratio [HR] 3.52, 95%\n                      <jats:italic>C<\/jats:italic>\n                      I 2.77\u20134.46), fentanyl (\n                      <jats:italic>HR<\/jats:italic>\n                      2.45, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      1.71\u20133.51), buprenorphine (\n                      <jats:italic>HR<\/jats:italic>\n                      2.43, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      1.54\u20133.82), combination opioids (\n                      <jats:italic>HR<\/jats:italic>\n                      2.22, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      1.63\u20133.02), and morphine (\n                      <jats:italic>HR<\/jats:italic>\n                      2.15, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      1.65\u20132.79) were associated with significantly higher delirium risk. No clear dose\u2013response association was observed: doses of 50\u2013119 MME\/day were not associated with a significant increase in risk compared to\u2009&lt;\u200950 MME\/day (\n                      <jats:italic>HR<\/jats:italic>\n                      0.96, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      0.66\u20131.39).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Using in-hospital medication administration records to capture opioid exposure, we found that oxycodone, fentanyl, buprenorphine, morphine, and combination\u00a0opioids were associated with increased delirium risk compared with codeine. Oxycodone was associated with a higher risk\u00a0of delirium compared with both codeine and morphine. These findings support personalised opioid prescribing in non-cancer pain and can inform shared clinical decision-making to prevent delirium in patients\u00a0prescribed opioids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04626-0","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:24:13Z","timestamp":1769822653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative risk of delirium among opioid users for non-cancer pain: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Carlos Raul Ramirez","family":"Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"10","key":"4626_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003270","volume":"17","author":"M Jani","year":"2020","unstructured":"Jani M, Birlie Yimer B, Sheppard T, Lunt M, Dixon WG. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: a retrospective cohort study. PLoS Med. 2020;17(10):e1003270.","journal-title":"PLoS Med"},{"issue":"3","key":"4626_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/j.pain.0000000000003402","volume":"166","author":"CR Ramirez Medina","year":"2025","unstructured":"Ramirez Medina CR, Lyon M, Davies E, McCarthy D, Reid V, Khanna A, et al. Clinical indications associated with new opioid use for pain management in the United Kingdom: using national primary care data. Pain. 2025;166(3):656\u201366.","journal-title":"Pain"},{"issue":"8","key":"4626_CR3","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s001340101017","volume":"27","author":"MJ Dubois","year":"2001","unstructured":"Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001;27(8):1297\u2013304.","journal-title":"Intensive Care Med"},{"issue":"1","key":"4626_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ageing\/afq140","volume":"40","author":"A Clegg","year":"2011","unstructured":"Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing. 2011;40(1):23\u20139.","journal-title":"Age Ageing"},{"issue":"1","key":"4626_CR5","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1038\/s41598-024-56675-1","volume":"14","author":"SH Yoo","year":"2024","unstructured":"Yoo SH, Kang J, Kim HJ, Lee SW, Hong M, Jung EH, et al. Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study. Sci Rep. 2024;14(1):6004.","journal-title":"Sci Rep"},{"issue":"5","key":"4626_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1164\/rccm.202104-0968ED","volume":"204","author":"CJ Hayhurst","year":"2021","unstructured":"Hayhurst CJ, Hughes CG, Pandharipande PP. The conundrum of pain, opiate use, and delirium: analgosedation or analgesia-first approach? Am J Respir Crit Care Med. 2021;204(5):502\u20133.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"4626_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40266-017-0455-9","volume":"34","author":"LM Swart","year":"2017","unstructured":"Swart LM, van der Zanden V, Spies PE, de Rooij SE, van Munster BC. The comparative risk of delirium with different opioids: a systematic review. Drugs Aging. 2017;34(6):437\u201343.","journal-title":"Drugs Aging"},{"issue":"10","key":"4626_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jpain.2013.05.010","volume":"14","author":"MS Cepeda","year":"2013","unstructured":"Cepeda MS, Fife D, Ma Q, Ryan PB. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study. J Pain. 2013;14(10):1227\u201341.","journal-title":"J Pain"},{"issue":"5","key":"4626_CR9","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/j.pain.0000000000003446","volume":"166","author":"M Jani","year":"2025","unstructured":"Jani M, Girard N, Bates DW, Buckeridge DL, Dixon WG, Tamblyn R. Comparative risk of mortality in new users of prescription opioids for noncancer pain: results from the International Pharmacosurveillance Study. Pain. 2025;166(5):1118\u201327.","journal-title":"Pain"},{"issue":"1","key":"4626_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04118-7","volume":"23","author":"BB Yimer","year":"2025","unstructured":"Yimer BB, Soomro M, McBeth J, Medina CRR, Lunt M, Dixon WG, et al. Comparative risk of severe constipation in patients treated with opioids for non-cancer pain: a retrospective cohort study in Northwest England. BMC Med. 2025;23(1):288.","journal-title":"BMC Med"},{"key":"4626_CR11","unstructured":"Steventon A, Keys H, Wittenberg R. Delirium: a neglected condition \u2013 but a potential opportunity for the NHS. NIHR Policy Research Unit in Dementia and Neurodegeneration (PRU-Dementia). 2023."},{"key":"4626_CR12","doi-asserted-by":"crossref","unstructured":"Anand A, Cheng M, Ibitoye T, Maclullich AMJ, Vardy E. Positive scores on the 4AT delirium assessment tool at hospital admission are linked to mortality, length of stay and home time: two-centre study of 82,770 emergency admissions. Age Ageing. 2022;51(3):afac051.","DOI":"10.1093\/ageing\/afac051"},{"key":"4626_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-341","volume":"13","author":"M Godfrey","year":"2013","unstructured":"Godfrey M, Smith J, Green J, Cheater F, Inouye SK, Young JB. Developing and implementing an integrated delirium prevention system of care: a theory driven, participatory research study. BMC Health Serv Res. 2013;13:341.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"4626_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01312-4","volume":"8","author":"CR Ram\u00edrez Medina","year":"2025","unstructured":"Ram\u00edrez Medina CR, Benitez-Aurioles J, Jenkins DA, Jani M. A systematic review of machine learning applications in predicting opioid associated adverse events. NPJ Digit Med. 2025;8(1):30.","journal-title":"NPJ Digit Med"},{"key":"4626_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00101","volume":"3","author":"S Martins","year":"2012","unstructured":"Martins S, Fernandes L. Delirium in elderly people: a review. Front Neurol. 2012;3:101.","journal-title":"Front Neurol"},{"issue":"3","key":"4626_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jpsychores.2008.05.019","volume":"65","author":"AMJ MacLullich","year":"2008","unstructured":"MacLullich AMJ, Ferguson KJ, Miller T, de Rooij SEJA, Cunningham C. Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res. 2008;65(3):229\u201338.","journal-title":"J Psychosom Res"},{"issue":"5","key":"4626_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0302888","volume":"19","author":"KA Sheehan","year":"2024","unstructured":"Sheehan KA, Shin S, Hall E, Mak DYF, Lapointe-Shaw L, Tang T, et al. Characterizing medical patients with delirium: a cohort study comparing ICD-10 codes and a validated chart review method. PLoS ONE. 2024;19(5):e0302888.","journal-title":"PLoS ONE"},{"issue":"6","key":"4626_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/pds.5595","volume":"32","author":"M Jani","year":"2023","unstructured":"Jani M, Yimer BB, Selby D, Lunt M, Nenadic G, Dixon WG. Take up to eight tablets per day\u201d: incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2023;32(6):651\u201360.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"15","key":"4626_CR19","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624\u201345.","journal-title":"JAMA"},{"key":"4626_CR20","unstructured":"NHS ENgland. National Early Warning Score (NEWS): NHS. Available from: https:\/\/www.england.nhs.uk\/ourwork\/clinical-policy\/sepsis\/nationalearlywarningscore\/."},{"key":"4626_CR21","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Care of deteriorating patients: consensus recommendations Edinburgh: SIGN; 2014 [SIGN publication no.139]. Available from: https:\/\/www.sign.ac.uk\/assets\/sign139.pdf."},{"issue":"5","key":"4626_CR22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.npp.1301471","volume":"33","author":"M Narita","year":"2008","unstructured":"Narita M, Nakamura A, Ozaki M, Imai S, Miyoshi K, Suzuki M, et al. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine. Neuropsychopharmacology. 2008;33(5):1097\u2013112.","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"4626_CR23","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/pme.12918","volume":"17","author":"MA Emery","year":"2016","unstructured":"Emery MA, Bates MLS, Wellman PJ, Eitan S. Differential effects of oxycodone, hydrocodone, and morphine on activation levels of signaling molecules. Pain Med. 2016;17(5):908\u201314.","journal-title":"Pain Med"},{"issue":"6","key":"4626_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305531","volume":"19","author":"YT Huang","year":"2024","unstructured":"Huang YT, Dixon WG, O\u2019Neill TW, Jani M. Postoperative opioids administered to inpatients with major or orthopaedic surgery: a retrospective cohort study using data from hospital electronic prescribing systems. PLoS ONE. 2024;19(6):e0305531.","journal-title":"PLoS ONE"},{"issue":"3","key":"4626_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.drugalcdep.2013.07.016","volume":"132","author":"JW Barwatt","year":"2013","unstructured":"Barwatt JW, Hofford RS, Emery MA, Bates ML, Wellman PJ, Eitan S. Differential effects of methadone and buprenorphine on the response of D2\/D3 dopamine receptors in adolescent mice. Drug Alcohol Depend. 2013;132(3):420\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"4626_CR26","doi-asserted-by":"crossref","unstructured":"Tanaka R, Ishikawa H, Sato T, Shino M, Matsumoto T, Mori K, et al. Incidence of delirium among patients having cancer injected with different opioids for the first time. Am J Hosp Palliat Med\u00ae. 2017;34(6):572\u20136.","DOI":"10.1177\/1049909116641274"},{"issue":"10","key":"4626_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1177\/10499091211065171","volume":"39","author":"Y Sugiyama","year":"2022","unstructured":"Sugiyama Y, Tanaka R, Sato T, Sato T, Saitoh A, Yamada D, et al. Incidence of delirium with different oral opioids in previously opioid-naive patients. Am J Hosp Palliat Care. 2022;39(10):1145\u201351.","journal-title":"Am J Hosp Palliat Care"},{"issue":"15","key":"4626_CR28","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/jama.2021.15255","volume":"326","author":"J Xie","year":"2021","unstructured":"Xie J, Strauss VY, Martinez-Laguna D, Carbonell-Abella C, Diez-Perez A, Nogues X, et al. Association of tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes. JAMA. 2021;326(15):1504\u201315.","journal-title":"JAMA"},{"issue":"8","key":"4626_CR29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/acem.14033","volume":"27","author":"R Daoust","year":"2020","unstructured":"Daoust R, Paquet J, Boucher V, Pelletier M, Gouin \u00c9, \u00c9mond M. Relationship between pain, opioid treatment, and delirium in older emergency department patients. Acad Emerg Med. 2020;27(8):708\u201316.","journal-title":"Acad Emerg Med"},{"issue":"1","key":"4626_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/acps.13505","volume":"147","author":"M Reisinger","year":"2023","unstructured":"Reisinger M, Reininghaus EZ, Biasi J, Fellendorf FT, Schoberer D. Delirium-associated medication in people at risk: a systematic update review, meta-analyses, and GRADE-profiles. Acta Psychiatr Scand. 2023;147(1):16\u201342.","journal-title":"Acta Psychiatr Scand"},{"key":"4626_CR31","doi-asserted-by":"crossref","unstructured":"Jani M, Girard N, Bates DW, Buckeridge DL, Sheppard T, Li J, et al. Opioid prescribing among new users for non-cancer pain in the USA, Canada, UK, and Taiwan: a population-based cohort study. PLoS Med. 2021;18(11):e1003829.","DOI":"10.1371\/journal.pmed.1003829"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04626-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:30:09Z","timestamp":1770769809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04626-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4626"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04626-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethics approval from the Health Research Authority (Reference 21\/EM\/0147; East Midlands Leicester South).This research has been approved by the Health Research Authority and the Confidentiality Advisory Group, which permit the use of patient data without individual consent. As part of this approval, researchers are required to inform patients about how their data are being used and provide them with the option to opt out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study used pseudonymised secondary data sources and did not involve any individual participant data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}